Literature DB >> 2914500

A rare endobronchial neurilemmoma (Schwannoma).

R J Feldhaus1, C Anene, P Bogard.   

Abstract

Primary neurogenic tumors of the lung are rare. Often, their histologic behavior presents a treatment dilemma. We present a case of benign endobronchial neurilemmoma managed by means of YAG laser resection together with a brief discussion of the management options available for these tumors.

Entities:  

Mesh:

Year:  1989        PMID: 2914500     DOI: 10.1378/chest.95.2.461

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  A schwannoma in the middle mediastinum originated from the phrenic nerve.

Authors:  Alpay Orki; Attila Ozdemir; Ayse A Ersev; Cemal A Kutlu
Journal:  Indian J Surg       Date:  2011-05-05       Impact factor: 0.656

2.  Optimal treatment for primary benign intratracheal schwannoma: A case report and review of the literature.

Authors:  Xiahui Ge; Fengfeng Han; Wenbin Guan; Jinyuan Sun; Xuejun Guo
Journal:  Oncol Lett       Date:  2015-07-21       Impact factor: 2.967

Review 3.  Intrapulmonary schwannoma.

Authors:  Takashi Ohtsuka; Hiroaki Nomori; Tsuguo Naruke; Hideki Orikasa; Kazuto Yamazaki; Keiichi Suemasu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-03

4.  Endobronchial schwannoma in adult: A case report.

Authors:  Touil Imen; Boudaya Mohamed Sadok; Aloui Raoudha; Souhir Ksissa; Brahem Yosra; Ben Attig Yosr; Ksontini Meriem; Bouchareb Soumaya; Keskes Boudawara Nadia; Boussoffara Leila; Knani Jalel
Journal:  Respir Med Case Rep       Date:  2021-03-19

5.  A case report of intrapulmonary schwannoma.

Authors:  Takuro Yukawa; Katsuhiko Shimizu; Yuji Hirami; Riki Okita; Shinsuke Saisho; Ai Maeda; Koichiro Yasuda; Masao Nakata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-03-23

6.  Bilateral benign endobronchial schwannomas.

Authors:  Ahmet Bircan; Nilgun Kapucuoglu; Onder Ozturk; Metin Ciris; Munire Gokirmak; Ahmed Akkaya
Journal:  Ann Saudi Med       Date:  2007 Sep-Oct       Impact factor: 1.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.